Needle | Jotup

Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2023

Retrieved on:

月曜日, 11月 13, 2023

Sale, Acquisition, Research, ART, HTL, Needle, Trade Adjustment Assistance, IVF, Azerion Group N.V., Hand, Software, Growth, Assisted reproductive technology, TSX, Pharmaceutical industry, Video game

and TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and nine months ended September 30, 2023.

Key Points:

and TORONTO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and nine months ended September 30, 2023.
David Wolf, President and Chief Executive Officer, of Hamilton Thorne Ltd. commented, “Sales grew 16% for the quarter while sales for the year were up 17%.
While some of this reduction is transient, with orders up for Q4, these trends have been impacting our business for some time; however, we expect we are likely reaching a bottom.
Constant currency sales as reported were up 12% for the quarter and 16% for the first nine months ended September 30, 2023.

Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals

Retrieved on:

木曜日, 12月 14, 2023

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV) bag recycling program pilot.

Key Points:

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV) bag recycling program pilot.
View the full release here: https://www.businesswire.com/news/home/20231214638041/en/
Photo of IV bag recycling provided by Northwestern Medicine.
All IV bags involved in this pilot were made of PVC, one of the most widely used plastic materials in medical products.
In recent years, Baxter has introduced several programs to facilitate recycling for patients and hospitals in Australia, New Zealand, Guatemala and Colombia.

Europe Syringes & Needles Insights Report 2023: A $7.97 Billion Market in 2022 - Forecasts to 2028 with BD, CardinalHealth, B Braun, Nipro, and Terumo Dominating - ResearchAndMarkets.com

Retrieved on:

水曜日, 12月 13, 2023

Medical Supplies, Health, Syringe, Research, Conditional sentence, Incidence, Element, B. Braun, Lead, Growth, Hospital, Diabetes, Video game, Needle

The "Europe Syringes & Needles Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Europe Syringes & Needles Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering.
This comprehensive report delves into the intricacies of the syringes and needles market in Europe, covering the period from 2023 to 2028.
It provides an extensive overview of various factors that are propelling the market growth, alongside potential restraints and emerging trends.
Key players like BD, CardinalHealth, B Braun, Nipro, and Terumo Corp are at the forefront of the European syringes & needles market.

United States Syringes & Needles Market Insights Report 2023: A $10.87 Billion Market by 2028 with BD, ICU Medical, Nipro Medical, Terumo, and Cardinal Health Emerging as Prominent Players - ResearchAndMarkets.com

Retrieved on:

月曜日, 12月 11, 2023

Medical Supplies, Health, Nipro, Sale, Syringe, Fungal infection, Conditional sentence, Incidence, ICU Medical, Cardinal Health, Hospital, Needle, Vaccination, Vaccine, Immunization, Cardinal, Diabetes, Anthrax Vaccine Immunization Program

This report offers market size & forecast data for the US syringes & needles market.

Key Points:

This report offers market size & forecast data for the US syringes & needles market.
This report provides a comprehensive and current market scenario of the US syringes & needles market, including the US syringes & needles market size, anticipated market forecast, relevant market segmentations, and industry trends.
The study considers a detailed scenario of the present US syringes & needles market and its market dynamics for 2023?2028.
BD, ICU Medical, Nipro Corporation, Terumo, and Cardinal Health are the key players in the US syringes and needles market.

Sol-Millennium Responds to FDA Safety Communication

Retrieved on:

土曜日, 12月 2, 2023

Medical Supplies, Health, FDA, Medical Devices, Infectious Diseases, Other Health, General Health, Communication, Syringe, Needle, Patient, COVID-19, Multimedia, ISO, Quality assurance, Medical device

Sol-Millennium, manufacturer of medical devices, including syringes for medicine delivery and testing, issued a statement regarding the FDA’s November 30 Safety Communication regarding syringes manufactured in China.

Key Points:

Sol-Millennium, manufacturer of medical devices, including syringes for medicine delivery and testing, issued a statement regarding the FDA’s November 30 Safety Communication regarding syringes manufactured in China.
The communication does not list manufacturers.
Sol-Millennium's manufacturing partners based in China adhere to stringent sampling techniques for raw material, in-process, and final inspections prior to product release.
Sol-Millennium seeks to reassure its customers and their patients that the firm places safety and reliability at the top of its concerns and efforts.

Filter Needles Market Size, Share & Trends Report 2023-2030: Global Analysis by Raw Material (Stainless Steel, Glass), and End-use (Hospital, Clinics, Ambulatory Surgery Centers) - ResearchAndMarkets.com

Retrieved on:

水曜日, 11月 29, 2023

The "Filter Needles Market Size, Share & Trends Analysis Report By Raw Material (Stainless Steel, Glass, Others), By End-use (Hospital, Clinics, Ambulatory Surgery Centers, Others), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Filter Needles Market Size, Share & Trends Analysis Report By Raw Material (Stainless Steel, Glass, Others), By End-use (Hospital, Clinics, Ambulatory Surgery Centers, Others), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global filter needles market size is expected to reach USD 2.9 billion by 2030.
The increasing geriatric population, technological advancements, and rising prevalence of chronic wounds are the key factors driving the market.
The increasing prevalence of various chronic wounds across the globe is anticipated to drive the market over the forecast period.

T-Mobile New Year's at the Needle Returns in Spectacular Fashion with Extended Show and Expanded Reach

Retrieved on:

木曜日, 12月 14, 2023

KREM, Space Needle, Hope, Pacific Northwest, Space, International Fountain, T-Mobile, KGW, Light, New Year's, UN, Fireworks, Needle

SEATTLE, Dec. 14, 2023 /PRNewswire/ -- The Space Needle is set to dazzle viewers at home and in-person this year, as the beloved T-Mobile New Year's at the Needle spectacular returns with an extended show and brand-new audiences. For the first time ever, Portland and Spokane will join the countdown to 2024 and watch as hundreds of lighted drones perform in the Seattle sky leading into the largest structurally launched firework show in North America, choreographed to a soundtrack celebrating the biggest moments of 2023.

Key Points:

"The Space Needle and West Coast represent the last major time zone to ring in the New Year.
The expanded 18-minute show will begin seven minutes before midnight with a performance by 500 drones illuminating the skies next to the Space Needle.
For an explosive main act, Pyro Spectacular by Souza will launch the firework extravaganza from the landmark itself.
This marks the 11th year T-Mobile has been the presenting sponsor of New Year's at the Needle.

Florida Realtors®: Deck the Halls Safely This Holiday Season

Retrieved on:

水曜日, 12月 6, 2023

Carbon, Human, Family, Needle, Research, Multimedia, Fire, Newsroom, Water

ORLANDO, Fla., Dec. 6, 2023 /PRNewswire/ -- As you're decking the halls this holiday season, be sure you're doing it safely.

Key Points:

ORLANDO, Fla., Dec. 6, 2023 /PRNewswire/ -- As you're decking the halls this holiday season, be sure you're doing it safely.
Here are some tips from Florida Realtors® to help you prepare your home for a happy holiday.
If you prefer a live tree, remember to water it daily so the needles stay moist and are less likely to catch fire.
Florida Realtors® serves as the voice for real estate in Florida.

Convergent Dental reaches new milestone as its Solea® All-Tissue Dental Laser is now being used by dentists in all 50 U.S. states

Retrieved on:

火曜日, 12月 5, 2023

Dentist, CO2, Patient, Anxiety, Digital technology, Needle, DMD, Education, Dentistry, Solea

WALTHAM, Mass., Dec. 5, 2023 /PRNewswire-PRWeb/ -- Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, announced today that the company's novel CO2 laser is now in use in Alaska, marking the first time that Solea laser dentistry is available to patients in all 50 U.S. states. North Coast Family Dentistry in Anchorage adopted the technology in July of this year.

Key Points:

Solea elevates practice possibilities and serves as a practice multiplier, allowing dentists to streamline existing procedures, add new treatments, and complement their digital technology.
"Since introducing Solea to our patients, we have seen a positive response and are already seeing the impact on our practice.
It's a 9.3-µm CO2 laser that allows for anesthesia-free, blood-free, and pain-free procedures in hard and soft tissue.
(1) Convergent Dental unites this novel technology with education & community, enabling dentists to elevate and grow their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.

Introworks Launching Agency Provides Marketing Communications Expertise to HistoSonics® as Revolutionary Med Tech Product Goes to Market

Retrieved on:

火曜日, 11月 28, 2023

Liver, Tissue, Needle, Patient, Marketing, Neoplasm, Partnership, Health, Pharmaceutical industry

The collaboration leveraged Introworks' expertise in strategic messaging, storytelling and breakthrough creative to ensure this groundbreaking medical technology receives the attention it deserves.

Key Points:

The collaboration leveraged Introworks' expertise in strategic messaging, storytelling and breakthrough creative to ensure this groundbreaking medical technology receives the attention it deserves.
"We are thrilled to have the opportunity to work closely with HistoSonics in launching this extraordinary new medical technology," said Bob Freytag, CEO of Introworks.
This product is especially rewarding because it allows us to directly contribute through our partnership to advancing a revolutionary medical technology."
Introworks Fractional Launch Navigators offer flexible marketing staffing support to ensure that critical launches and initiatives meet company timelines and goals.